Integrating hope and patient-centered approaches is essential for participant retention and trial success in clinical oncology. These trials hinge on collaborative trial design involving patients and caregivers, which can improve adherence and outcomes.
Read our article, where we discuss the following:
- The value of real-world data from patient diaries and support groups, which provide insights into treatments’ daily impact and patients’ emotional well-being.
- The various dimensions of hope, including access to innovative therapies, personal health benefits, trust in medical teams, enhanced monitoring, altruism, and financial support.
- Future medical research directions that are increasingly balancing scientific rigor with clinical care and human compassion to make trials more relevant and responsive.
